NO862956L - Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidin-derivater. - Google Patents
Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidin-derivater.Info
- Publication number
- NO862956L NO862956L NO86862956A NO862956A NO862956L NO 862956 L NO862956 L NO 862956L NO 86862956 A NO86862956 A NO 86862956A NO 862956 A NO862956 A NO 862956A NO 862956 L NO862956 L NO 862956L
- Authority
- NO
- Norway
- Prior art keywords
- procedure
- preparation
- pyrimidine derivatives
- therapeutic active
- active pyrimidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/758,199 US4711888A (en) | 1985-07-24 | 1985-07-24 | Hydroxy and alkoxy pyrimidines |
Publications (4)
Publication Number | Publication Date |
---|---|
NO862956D0 NO862956D0 (no) | 1986-07-23 |
NO862956L true NO862956L (no) | 1987-01-26 |
NO173442B NO173442B (no) | 1993-09-06 |
NO173442C NO173442C (no) | 1993-12-15 |
Family
ID=25050889
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO862956A NO173442C (no) | 1985-07-24 | 1986-07-23 | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidinderivater |
Country Status (25)
Country | Link |
---|---|
US (1) | US4711888A (no) |
EP (1) | EP0210044B1 (no) |
JP (1) | JPH0647579B2 (no) |
KR (1) | KR890001549B1 (no) |
CN (1) | CN1006792B (no) |
AU (1) | AU569194B2 (no) |
CA (1) | CA1265519A (no) |
DD (1) | DD248588A5 (no) |
DE (1) | DE3673718D1 (no) |
DK (1) | DK162986C (no) |
EG (1) | EG18181A (no) |
ES (1) | ES2000734A6 (no) |
FI (1) | FI89911C (no) |
GR (1) | GR861917B (no) |
HU (1) | HU196764B (no) |
IE (1) | IE63404B1 (no) |
IL (1) | IL79471A0 (no) |
NO (1) | NO173442C (no) |
NZ (1) | NZ216951A (no) |
PH (1) | PH22484A (no) |
PL (2) | PL151571B1 (no) |
PT (1) | PT83036B (no) |
SU (1) | SU1574171A3 (no) |
YU (1) | YU45020B (no) |
ZA (1) | ZA865489B (no) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG47583A1 (en) * | 1986-01-13 | 1998-04-17 | American Cyanamid Co | 4,5,6-Substituted-n- (substituted-phenyl) -2- pyrimidinamines |
US4959365A (en) * | 1986-10-31 | 1990-09-25 | Pfizer Inc. | Topical compositions of lipophilic pharmaceuticals agents |
HU199683B (en) * | 1987-07-22 | 1990-03-28 | Egyt Gyogyszervegyeszeti Gyar | Process for producing pharmaceutical compositions analgesic, antiphlogistic, antipyretic, antianginic and/or antioxidative activity |
HU206203B (en) * | 1987-12-02 | 1992-09-28 | Pfizer | Process for producing acyl derivatives of hydroxypyrimidines |
US5071852A (en) * | 1988-12-14 | 1991-12-10 | Pfizer Inc. | Derivatives of 5-hydroxy and 5-methoxy 2-amino-pyrimidines as inhibitors of interleukin-1 production |
EP0373827B1 (en) * | 1988-12-14 | 1993-10-27 | Pfizer Inc. | Derivatives of 5-hydroxy and 5-methoxy 2-amino-pyrimidines as inhibitors of interleukin-1 production |
US4940712A (en) * | 1989-05-26 | 1990-07-10 | Pfizer Inc. | Derivatives of hydroxyprimidines as leukotriene synthesis inhibitors |
US5248682A (en) * | 1991-01-31 | 1993-09-28 | Warner-Lambert Company | 2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents |
EP0569493A4 (en) * | 1991-01-31 | 1993-11-24 | Warner-Lambert Company | Substituted 4,6-di-tertiary-butyl-5-hydroxy-pyrimidines |
US5177079A (en) * | 1991-01-31 | 1993-01-05 | Warner-Lambert Company | 2-substituted-4,6-di-tertiarybutyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents |
US5270319A (en) * | 1991-09-09 | 1993-12-14 | Warner-Lambert Company | 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents |
US5196431A (en) * | 1992-02-24 | 1993-03-23 | Warner-Lambert Company | 2-substituted amino-4, 6-di-tertiary-buthyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents |
US5220025A (en) * | 1992-02-24 | 1993-06-15 | Warner-Lambert Company | 2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents |
WO1997043265A1 (fr) * | 1996-05-16 | 1997-11-20 | Nissan Chemical Industries, Ltd. | Procedes de preparation d'un compose pyrimidine |
US5952331A (en) * | 1996-05-23 | 1999-09-14 | Syntex (Usa) Inc. | Aryl pyrimidine derivatives |
TW440563B (en) * | 1996-05-23 | 2001-06-16 | Hoffmann La Roche | Aryl pyrimidine derivatives and a pharmaceutical composition thereof |
US5958934A (en) * | 1996-05-23 | 1999-09-28 | Syntex (U.S.A.) Inc. | Aryl pyrimidine derivatives and uses thereof |
US7045519B2 (en) | 1998-06-19 | 2006-05-16 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
ATE274510T1 (de) | 1998-06-19 | 2004-09-15 | Chiron Corp | Glycogen synthase kinase 3 inhibitoren |
AU2001280445A1 (en) * | 2000-06-23 | 2002-01-08 | Vanderbilt University | Novel chain-breaking antioxidants |
DE102004054080A1 (de) * | 2004-11-09 | 2006-05-11 | Wella Ag | Haut- oder Haarbehandlungsmittel mit Schutzeffekt |
US9133212B1 (en) | 2005-06-15 | 2015-09-15 | Vanderbilt University | Inhibitors of hemeprotein-catalyzed lipid peroxidation |
US8367669B2 (en) * | 2005-06-15 | 2013-02-05 | Vanderbilt University | Inhibitors of hemeprotein-catalyzed lipid peroxidation |
JP2008156048A (ja) * | 2006-12-22 | 2008-07-10 | Isamu Nakamura | 車両用板材キャリア |
US8877766B2 (en) | 2013-02-15 | 2014-11-04 | Peter F. Kador | Neuroprotective multifunctional antioxidants and their monofunctional analogs |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN153791B (no) * | 1979-03-10 | 1984-08-18 | Soc D Etudes Prod Chimique | |
US4659363A (en) * | 1983-07-25 | 1987-04-21 | Ciba-Geigy Corporation | N-(2-nitrophenyl)-2-aminopyrimidine derivatives, the preparation and use thereof |
US4554276A (en) * | 1983-10-03 | 1985-11-19 | Pfizer Inc. | 2-Amino-5-hydroxy-4-methylpyrimidine derivatives |
EP0164204A1 (en) * | 1984-05-12 | 1985-12-11 | FISONS plc | Novel pharmaceutically useful pyrimidines |
-
1985
- 1985-07-24 US US06/758,199 patent/US4711888A/en not_active Expired - Lifetime
-
1986
- 1986-07-16 DE DE8686305466T patent/DE3673718D1/de not_active Expired - Fee Related
- 1986-07-16 EP EP86305466A patent/EP0210044B1/en not_active Expired - Lifetime
- 1986-07-21 IL IL79471A patent/IL79471A0/xx not_active IP Right Cessation
- 1986-07-22 EG EG453/86A patent/EG18181A/xx active
- 1986-07-22 PT PT83036A patent/PT83036B/pt not_active IP Right Cessation
- 1986-07-22 CA CA000514336A patent/CA1265519A/en not_active Expired - Fee Related
- 1986-07-22 GR GR861917A patent/GR861917B/el unknown
- 1986-07-23 AU AU60447/86A patent/AU569194B2/en not_active Ceased
- 1986-07-23 IE IE195286A patent/IE63404B1/en not_active IP Right Cessation
- 1986-07-23 NO NO862956A patent/NO173442C/no unknown
- 1986-07-23 SU SU864027808A patent/SU1574171A3/ru active
- 1986-07-23 FI FI863029A patent/FI89911C/fi not_active IP Right Cessation
- 1986-07-23 DD DD86292804A patent/DD248588A5/de not_active IP Right Cessation
- 1986-07-23 NZ NZ216951A patent/NZ216951A/xx unknown
- 1986-07-23 ES ES8600529A patent/ES2000734A6/es not_active Expired
- 1986-07-23 ZA ZA865489A patent/ZA865489B/xx unknown
- 1986-07-23 PH PH34054A patent/PH22484A/en unknown
- 1986-07-23 DK DK349486A patent/DK162986C/da active
- 1986-07-23 YU YU1321/86A patent/YU45020B/xx unknown
- 1986-07-23 HU HU863000A patent/HU196764B/hu not_active IP Right Cessation
- 1986-07-23 CN CN86104539A patent/CN1006792B/zh not_active Expired
- 1986-07-23 KR KR1019860005974A patent/KR890001549B1/ko not_active IP Right Cessation
- 1986-07-24 JP JP61174704A patent/JPH0647579B2/ja not_active Expired - Lifetime
- 1986-07-24 PL PL1986271856A patent/PL151571B1/pl unknown
- 1986-07-24 PL PL1986260784A patent/PL150617B1/pl unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO864126D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater. | |
NO163406C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater. | |
NO871266L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. | |
NO862477D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater. | |
NO862956D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidin-derivater. | |
NO883974L (no) | Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater. | |
NO853293L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater. | |
NO870526L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater. | |
NO874032D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater. | |
NO864879L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser. | |
NO864674D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser. | |
NO871588L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske karboksamider. | |
NO862373D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner. | |
NO871044L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidinderivater. | |
NO864130D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive karboksamid-derivater. | |
NO875488L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater. | |
NO171592C (no) | Fremgangsmaate for fremstilling av aktive cinnolin-derivater | |
NO864131D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive indol-og indazol-ketosulfon-derivater. | |
NO164897C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater. | |
NO862372D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater. | |
NO861584L (no) | Fremgangsmaate til fremstilling av terapeutisk aktive cyklopentyletere. | |
NO865012D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive benzazepinderivater. | |
NO864101D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater. | |
NO162072C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyridinderivater. | |
NO871907D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater. |